How Resilient Is 23andMe Company's Target Market and Customer Base?

By: Brendan Gaffey • Financial Analyst

23andMe Bundle

Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10

How durable is 23andMe Holding Co.'s demand base?

23andMe Holding Co.'s demand base looks fragile after its March 2025 Chapter 11 filing and $305 million asset sale. The core risk is trust: a 2023 data breach and weak repeat use can limit paid conversion. That makes customer retention and subscriptions the key test.

How Resilient Is 23andMe Company's Target Market and Customer Base?

Its historical base of 15 million customers helps, but one-time kit demand is not durable on its own. The real upside depends on turning that audience into recurring health users, as shown in the 23andme soar analysis.

Who Are 23andMe's Core Customers?

23andMe Holding Co.'s core customers are health-motivated affluent consumers and pharmaceutical research partners. That mix supports the 23andMe target market because one group drives subscription demand, while the other supports revenue stability through research data use.

Icon Health-focused affluent subscribers anchor demand

The most important segment in the 23andMe customer base is adults aged 35 – 65 who want health insights, ancestry, and ongoing access. More than 70% of users hold a bachelor's degree or higher, and typical household income levels above $80,000 to $100,000 fit premium offers like the $1,189 annual Total Health membership. That profile supports stronger 23andMe consumer demand than a purely price-led DNA test market.

Icon Price-sensitive one-time buyers are the most exposed

The most vulnerable segment is the broader direct-to-consumer DNA testing buyer who may shop only during promotions or holidays. This group is more exposed to weak consumer interest in ancestry testing and to price pressure, so repeat use is less certain. For more on that risk profile, see Business Model Risks of 23andMe Company.

On the B2B side, pharmaceutical research partners are a key support for 23andMe market resilience. About 80% of users opt into research, which turns consented genetic data into a high-margin asset; that helped drive $19.3 million in non-recurring revenue in Q3 FY2025 even after exclusive collaboration terms ended.

23andMe SOAR Analysis

  • Designed for Fast Business Analysis
  • Fully Customizable
  • Editable in Excel & Word
  • Professional Formatting
  • Investor-Ready Format
Get Related Template

What Makes Demand for 23andMe Durable or Fragile?

23andMe Holding Co. demand is more durable when tied to health management, since membership and repeat reports can recur. It is more fragile for ancestry kits, where the $99 – $229 price and trust issues can slow purchases and lift churn.

Icon

Demand durability in the 23andMe target market

Health-linked demand is the steadier part of the 23andMe customer base. Late 2024 data showed 23andMe+ membership contributed over 21% of revenue, helped by updated polygenic risk scores and personalized guidance. That makes Risk History of 23andMe Company central to understanding how trust shapes repeat use.

  • Repeat demand comes from health memberships.
  • Price cuts still matter for kit sales.
  • Health need is stronger than ancestry curiosity.
  • Durability is mixed, not fully stable.

23andMe Ansoff Matrix

  • Simple to Edit, Customize, and Share
  • No Research Needed – Save Hours of Work
  • Built by Experts, Trusted by Consultants
  • Instant Download, Ready to Use
  • 100% Editable, Fully Customizable
Get Related Template

Where Is 23andMe's Demand Most Exposed?

23andMe Holding Co.'s demand is most exposed in the United States, where about 85% of its consumer base sits, and in high-income states like California, New York, and Massachusetts. That makes the 23andMe target market sensitive to US income pressure, state privacy rules, and any drop in direct-to-consumer DNA testing demand.

Demand Area Main Exposure Why It Matters
United States consumer base Geographic concentration About 85% of customers are in one market, so US regulation and demand shifts hit hard.
California, New York, Massachusetts Income and education concentration High-income, high-health-literacy hubs drive kit adoption, but they also amplify local demand swings.
PGS and Lemonaid Health Revenue concentration These divisions reached about 97% of FY2025 Q1 revenue, so weakness there directly pressures 23andMe revenue by customer segment.
Bankruptcy-related data transfer Regulatory and trust risk State lawsuits in 2025 over user data transfer show how privacy fears can weaken 23andMe consumer demand.

The risk matters most where the 23andMe customer base is narrow and trust is fragile: US households with enough disposable income to buy kits, then stay engaged with health reports, subscriptions, or telehealth. That makes 23andMe market resilience tied less to broad mass demand and more to how stable direct-to-consumer DNA testing demand stays under privacy scrutiny, tighter spending, and weaker repeat use. For a deeper read on the pressure points, see Competitive Pressures Facing 23andMe Company.

23andMe Balanced Scorecard

  • Clear Sections for Easy Navigation
  • Effortlessly Communicate Your Business Strategy
  • Investor-Ready Format
  • 100% Editable and Customizable
  • Clear and Structured Layout
Get Related Template

How Does 23andMe Retain Demand Under Pressure?

23andMe Holding Co. is trying to hold demand by moving from one-time kits to recurring health services. Two-step verification, the Biological Age feature, and the Total Health program help keep the 23andMe customer base active even as trust and spending stay under pressure.

Icon

Best support for repeat demand

The strongest support for 23andMe market resilience is the shift to ongoing clinical use. Whole exome sequencing and bi-annual blood biomarker testing in Total Health can raise retention because customers return for updates, not just a single kit purchase. That matters in the genetic testing market, where repeat use is harder to build than first-time interest.

Icon

Main risk to demand

The biggest risk is trust. Privacy concerns can slow new sign-ups and cut 23andMe consumer demand, even with added security. The Growth Risks of 23andMe Company piece is relevant here because the business still depends on keeping users willing to share sensitive DNA data.

That makes the 23andMe target market more durable on the health side than on the kit side. Late 2024 membership services revenue more than doubled year over year, while kit sales fell, which points to real demand among core users and stronger 23andMe repeat customers and retention than the wider direct-to-consumer DNA testing market usually gets.

Still, the 40 percent workforce cut in early 2025 shows the pressure is real. The 23andMe customer demographics analysis likely favors users who want ongoing health reports, so the key question is who is the target customer of 23andMe now: casual ancestry buyers, or higher-value members willing to pay for continuous monitoring.

23andMe SWOT Analysis

  • Ready-to-Use Framework for Decision Making
  • Structured for Consultants, Students, and Founders
  • 100% Editable in Microsoft Word & Excel
  • Instant Digital Download – Use Immediately
  • Compatible with Mac & PC – Fully Unlocked
Get Related Template


Related Blogs

Frequently Asked Questions

23andMe Holding Co. completed an asset sale in mid-2025 to TTAM Research Institute, a nonprofit led by founder Anne Wojcicki, for $305 million . This occurred after a bidding war with Regeneron Pharmaceuticals and followed a Chapter 11 filing in March 2025 . The transition aimed to protect genetic data for 13-15 million customers and stabilize the firm's core DNA-testing services .

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.